SKINNasdaqSurgical & Medical Instruments & ApparatusUS GAAP · USD

SkinHealth Systems Inc.

SkinHealth Systems Inc. is a U.S.-based medical aesthetics company that designs, manufactures, and sells skin-health treatment systems and related consumables. Its portfolio centers on Hydrafacial delivery systems and proprietary treatment solutions, with additional offerings in microneedling and scalp-health treatments sold through a global network of providers.

Kysy yhtiöstä
Liikevaihto301milj. USD
−10,0 %v/v
Liikevoitto (EBIT)−20,8milj. USD
+69,3 %v/v
EBIT-marginaali−6,9%
+13,4 %-yks.v/v
Nettotulos−9,5milj. USD
+67,3 %v/v
Vapaa kassavirta37,2milj. USD
+141,8 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−2000200400milj. USD2020: 119 milj. USD2020: EBIT −1,2 milj. USD20202021: 260 milj. USD2021: EBIT −40 milj. USD20212022: 366 milj. USD2022: EBIT −24 milj. USD20222023: 398 milj. USD2023: EBIT −131 milj. USD20232024: 334 milj. USD2024: EBIT −68 milj. USD20242025: 301 milj. USD2025: EBIT −21 milj. USD2025301−21
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: SkinHealth Systems Inc.

Liiketoiminta

Osuus liikevaihdosta
Delivery Systems29 %

Capital equipment used by providers to perform Hydrafacial treatments.

Consumables71 %

Recurring-use tips, solutions, and serums consumed during treatments.

Tuotteet

Raportoitu · osuus liikevaihdosta
70,7%29,3%FY2025100 %
  • Consumables70,7 %
  • Delivery Systems29,3 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

The company sells primarily to licensed providers in the professional medical and aesthetic channels, including dermatologists, plastic surgeons, medical spas, estheticians, and beauty retailers. These customers buy the systems to offer in-office skin treatments and buy consumables repeatedly as treatment volume grows. The business also reaches spas, hotels, and other retailers that use the platform to broaden service offerings.

Professional medical providers

Dermatologists, plastic surgeons, and medical practices buy systems and consumables to offer in-office aesthetic treatments.

Medical spas and estheticians

These providers use the devices to deliver branded skin treatments and expand service menus.

Beauty retail and hospitality channels

Spas, hotels, and retailers buy treatments and equipment to add premium skin-health services.

Strategia

The company is focused on expanding its installed base of delivery systems and increasing utilization so consumables become a larger share of revenue. It is also investing in brand building, provider education, digital marketing, and commercial analytics to strengthen demand and retention across its platform. Product innovation in Hydrafacial, SkinStylus, and HydraScalp remains central to broadening the treatment portfolio and supporting provider economics.

Grow the installed base and utilizationKeskipitkä aikaväli

More active systems create a larger recurring consumables stream and deepen provider dependence on the platform.

Expand consumer demand generationLyhyt aikaväli

Consumer pull helps providers fill appointments and increases treatment frequency.

Broaden the product portfolioKeskipitkä aikaväli

Additional treatment categories can increase wallet share within provider practices.

Maantiede

Q2/2026

The company operates globally, with direct sales in some countries and distributor or hybrid models in others. Management disclosed that markets outside the United States and Canada represented about 35% of net sales in fiscal 2025, showing a meaningful international footprint. China is now served through a distributor partner rather than direct sales, which changes how the company reaches that market.

Americas69 %
EMEA21 %
Asia Pacific10 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

The business faces intense competition in a fragmented beauty and medical aesthetics market, where pricing, brand strength, and product innovation can shift quickly. It is also exposed to regulatory scrutiny over product claims, adverse events, and recalls, plus supply-chain, tariff, and foreign-exchange pressures tied to its global footprint. Because consumables depend on installed-base utilization, any slowdown in provider adoption or treatment volume can weaken recurring demand.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Competitive pressure in beauty health and medical aesthetics1Regulatory and claims substantiation risk2Product safety and recall risk3International and supply-chain exposure4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Competitive pressure in beauty health and medical aestheticsVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The market is fragmented and rivals offer similar devices and treatments at aggressive prices.

    KohdistuuPricingBrand shareProvider retention
  2. Regulatory and claims substantiation riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    FDA, FTC, and foreign regulators can challenge marketing claims or product classifications.

    KohdistuuAdvertisingProduct labelingMarket access
  3. Product safety and recall riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Adverse events or device defects can trigger reporting obligations, recalls, and reputational damage.

    Kohdistuu: Device reliability and clinical use

  4. International and supply-chain exposureVaikutus: KeskitasoTodennäköisyys: Korkea

    Global sourcing and distribution create exposure to tariffs, logistics disruptions, and currency moves.

    Kohdistuu: Manufacturing inputs and overseas sales

Kysy Clarifolta: SkinHealth Systems Inc.

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition timing

Shipment-based recognition can shift revenue between periods when orders or channel inventory change.

Vaikutus: Quarterly comparability and reported growth rates

Trade-in and refurbished device estimates

Management estimates resale value, refurbishment cost, and margin for returned devices.

Vaikutus: Revenue, inventory carrying value, and gross profit

Goodwill and intangible impairment

Acquired assets are tested for recoverability using forecast-driven valuation models.

Vaikutus: Potential non-cash impairment charges

Deferred tax asset valuation allowance

Cumulative losses affect whether future tax benefits are considered realizable.

Vaikutus: Income tax expense and net deferred tax assets

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Skinvisible, Inc.

SKVI · Pharmaceutical Preparations

BioScience Health Innovations, Inc.

BHIC · Services-Computer Processing & Data Preparation

Longevity Health Holdings, Inc.

XAGE · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics

InfuSystem Holdings, Inc

INFU · Surgical & Medical Instruments & Apparatus

Hims & Hers Health, Inc.

HIMS · Services-Offices & Clinics of Doctors of Medicine

Sensus Healthcare, Inc.

SRTS · Surgical & Medical Instruments & Apparatus

Päivitetty: 24.9.2026